← Return to Boehringer Ingelheim AIRTIVITY clinical trial
DiscussionBoehringer Ingelheim AIRTIVITY clinical trial
MAC & Bronchiectasis | Last Active: Jul 6 7:30am | Replies (48)Comment receiving replies
Replies to "She frequently felt unwell and experienced multiple exacerbations each year. These recurring illnesses disrupted her ability..."
What a success story. How fabulous for her! I hope the rest of us are as fortunate as she.
Do you think this means that she was able to scale back on airway clearance? Or maybe brensocatib reduced the phlegm so clearance times were shorter? We all know that everyone is different, so we'll just have to wait and see how it works for each of us. Fingers crossed. Thanks @becleartoday for sharing such a positive report.